AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22583956 — intervention group
Group type: COMPARATOR
Intervention: High threat photos
Number of subjects: 64
Study 20025642 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg melatonin for 21 days
Number of subjects: 19
Study 20025642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 18201810 — intervention group
Group type: EXPERIMENTAL
Intervention: YGS (yi-gan san) 7.5 g/day for 12 weeks
Number of subjects: 22
Study 15919151 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled sleep/darkness
Number of subjects: 0
Study 15919151 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 12633920 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid (prednisolone 2 mg/kg per day)
Number of subjects: 80
Study 12633920 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihistamine (chlorpheniramine maleate 0.35 mg/kg per day)
Number of subjects: 80
Study 12633920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 10389090 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 24
Study 10389090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 10389090 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (combined group of normal and narcoleptic subjects)
Number of subjects: 24
Study 10389090 — intervention group
Group type: COMPARATOR
Intervention: Placebo (combined group of normal and narcoleptic subjects)
Number of subjects: 24
Study 8778359 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique for studying incision depth
Number of subjects: 0
Study 1712957 — intervention group
Group type: EXPERIMENTAL
Intervention: VVIR pacing mode
Number of subjects: 11
Study 1712957 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing mode
Number of subjects: 11
Study 6406439 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 0
Study 6406439 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 30714880 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT-Buprenorphine
Number of subjects: 20
Study 30714880 — intervention group
Group type: COMPARATOR
Intervention: Standard buprenorphine treatment
Number of subjects: 20
Study 28213645 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left dorsolateral prefrontal cortex (DLPFC, 1 mA, 20 min)
Number of subjects: 16
Study 28213645 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16
Study 26355615 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 1.2% and benzoyl peroxide 3.75% aqueous gel
Number of subjects: 498
Study 26355615 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 498
Study 23697871 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) program
Number of subjects: 200
Study 23697871 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control group
Number of subjects: 200
Study 20732776 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based behavioral modification program with telephone support
Number of subjects: 92
Study 19999359 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour reading aloud task (exercise)
Number of subjects: 9
Study 19999359 — intervention group
Group type: COMPARATOR
Intervention: 24-hour period of complete voice rest (control)
Number of subjects: 9
Study 19999359 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose injection plus exercise
Number of subjects: 9
Study 15987748 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF group (n = 54)
Number of subjects: 108
Study 15987748 — intervention group
Group type: COMPARATOR
Intervention: CsA group (n = 54)
Number of subjects: 108
Study 12888370 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence screening
Number of subjects: 0
Study 12888370 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence screening
Number of subjects: 0
Study 12888370 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-progressive DCIS (DCIS(0))
Number of subjects: 0
Study 12888370 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive DCIS (DCIS(1))
Number of subjects: 0
Study 18425650 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward (special dessert)
Number of subjects: 64
Study 18425650 — intervention group
Group type: EXPERIMENTAL
Intervention: Insisting children try one bite
Number of subjects: 64
Study 18425650 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice-offering ('Do you want any of this?')
Number of subjects: 64
Study 18425650 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling
Number of subjects: 64
Study 18425650 — intervention group
Group type: COMPARATOR
Intervention: Simple exposure (control condition)
Number of subjects: 64
Study 8664370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 8-hour training course and supporting materials
Number of subjects: 0
Study 1829177 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydantoin injection followed by dose-adjusted oral administration for a minimum of 3 months
Number of subjects: 86
Study 1829177 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 86
Study 6222257 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 10
Study 6222257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31713863 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended anticoagulation
Number of subjects: 281
Study 31713863 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (limited duration anticoagulation)
Number of subjects: 281
Study 31713863 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer results (on anticoagulation)
Number of subjects: 281
Study 30523703 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA plus usual care (TU)
Number of subjects: 106
Study 30523703 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 106
Study 28216012 — intervention group
Group type: EXPERIMENTAL
Intervention: HMME group (treated with Hemoporfin)
Number of subjects: 50
Study 28216012 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (given normal saline)
Number of subjects: 50
Study 28216012 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (received HMME-PDT treatment in the second session)
Number of subjects: 50
Study 26797500 — intervention group
Group type: EXPERIMENTAL
Intervention: LL group (three standard fluoroscopic views + LL fluoroscopic view)
Number of subjects: 143
Study 26797500 — intervention group
Group type: COMPARATOR
Intervention: Standard group (three standard fluoroscopic views)
Number of subjects: 143
Study 23905837 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (n=20)
Number of subjects: 198
Study 23905837 — intervention group
Group type: COMPARATOR
Intervention: Sulfonylurea (n=24)
Number of subjects: 198
Study 22015710 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured diet and exercise (DE)
Number of subjects: 16
Study 22015710 — intervention group
Group type: COMPARATOR
Intervention: DE plus metformin
Number of subjects: 16
Study 22015710 — intervention group
Group type: EXPERIMENTAL
Intervention: DE (with improvement in V˙O2max)
Number of subjects: 16
Study 19356395 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of levofloxacin 500 mg
Number of subjects: 27
Study 19356395 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of levofloxacin 500 mg
Number of subjects: 27
Study 17637533 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy
Number of subjects: 0
Study 17637533 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine
Number of subjects: 0
Study 17637533 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 0
Study 16639920 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA): 3 mg dissolved in 250 mg of physiological saline given every 12 hours for a maximum of 20 days.
Number of subjects: 150
Study 16639920 — intervention group
Group type: COMPARATOR
Intervention: Standard dosage of rt-PA used for treatment of myocardial infarction (not specified in the abstract).
Number of subjects: 150
Study 11817910 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE+ intervention (computerized assessment and tailored action plans)
Number of subjects: 173
Study 11817910 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 173
Study 11817910 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail only, infrequent phone and mail, frequent phone and mail (extended intervention conditions)
Number of subjects: 173
Study 9469313 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial components inserted with cement
Number of subjects: 26
Study 9469313 — intervention group
Group type: COMPARATOR
Intervention: Tibial components inserted without cement
Number of subjects: 26
Study 9469313 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without cement)
Number of subjects: 26
Study 10150841 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia
Number of subjects: 0
Study 10150841 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar anesthesia
Number of subjects: 0
Study 10150841 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs
Number of subjects: 0
Study 10150841 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic use
Number of subjects: 0
Study 2216299 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA) 45 mg/m2 orally on 3 consecutive days every 28 days
Number of subjects: 63
Study 2216299 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (ADRIA) 75 (60) mg/m2 intravenously every 21 days
Number of subjects: 63
Study 2216299 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (IDA and ADRIA)
Number of subjects: 63
Study 2216299 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA)
Number of subjects: 63
Study 2216299 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (ADRIA)
Number of subjects: 63
Study 358756 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (intramuscular injections)
Number of subjects: 91
Study 358756 — intervention group
Group type: COMPARATOR
Intervention: Barbital (oral route)
Number of subjects: 91
Study 30844309 — intervention group
Group type: EXPERIMENTAL
Intervention: High Fiber White Rice (HFWR) diet
Number of subjects: 18
Study 30844309 — intervention group
Group type: COMPARATOR
Intervention: Regular White Rice (RWR) diet
Number of subjects: 18
Study 28860461 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-phone-based smoking cessation intervention
Number of subjects: 0
Study 26019183 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose THC (2.9%) with alcohol
Number of subjects: 32
Study 26019183 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose THC (6.7%) with alcohol
Number of subjects: 32
Study 26019183 — intervention group
Group type: COMPARATOR
Intervention: Low-dose THC (2.9%) without alcohol
Number of subjects: 32
Study 26019183 — intervention group
Group type: COMPARATOR
Intervention: High-dose THC (6.7%) without alcohol
Number of subjects: 32
Study 26019183 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo with alcohol
Number of subjects: 32
Study 26019183 — intervention group
Group type: COMPARATOR
Intervention: Placebo without alcohol
Number of subjects: 32
Study 23530566 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai traditional massage (2-hour session, twice a week for 4 weeks)
Number of subjects: 48
Study 23530566 — intervention group
Group type: COMPARATOR
Intervention: Control period (no massage)
Number of subjects: 48
Study 23530566 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai traditional massage (specific subgroup: postmenopausal women in middle and higher tertiles of age and lower and middle tertiles of height)
Number of subjects: 48
Study 23530566 — intervention group
Group type: COMPARATOR
Intervention: Control period (specific subgroup)
Number of subjects: 48
Study 21668961 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional exercise program including sit-ups (TEP) with psychosocial educational program (PSEP)
Number of subjects: 4325
Study 21668961 — intervention group
Group type: COMPARATOR
Intervention: Traditional exercise program including sit-ups (TEP) without psychosocial educational program (PSEP)
Number of subjects: 4325
Study 21668961 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercise program (CSEP) with psychosocial educational program (PSEP)
Number of subjects: 4325
Study 21668961 — intervention group
Group type: COMPARATOR
Intervention: Core stabilization exercise program (CSEP) without psychosocial educational program (PSEP)
Number of subjects: 4325
Study 19159408 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg daily) for 10 days
Number of subjects: 91
Study 19159408 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further treatment)
Number of subjects: 91
Study 16825288 — intervention group
Group type: COMPARATOR
Intervention: Low-dose amiodarone alone
Number of subjects: 177
Study 16825288 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone plus losartan
Number of subjects: 177
Study 16825288 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone plus perindopril
Number of subjects: 177
Study 12476528 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSO
Number of subjects: 0
Study 12476528 — intervention group
Group type: EXPERIMENTAL
Intervention: PPS
Number of subjects: 0
Study 12476528 — intervention group
Group type: COMPARATOR
Intervention: BCG
Number of subjects: 0
Study 12476528 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid
Number of subjects: 0
Study 12476528 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral nerve root stimulation
Number of subjects: 0
Study 10441849 — intervention group
Group type: EXPERIMENTAL
Intervention: haemocorrecting drugs (rheopolyglucin, euphyllin, aspirin, curantyl, trental)
Number of subjects: 36
Study 10441849 — intervention group
Group type: COMPARATOR
Intervention: vasoactive and metabolic drugs (cavinton, complamin, actovegin)
Number of subjects: 36
Study 7790793 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐dose, motorized, continuous traction (35%-50% of total body weight)
Number of subjects: 0
Study 7790793 — intervention group
Group type: COMPARATOR
Intervention: Sham or low‐dose traction (0-20% of body weight)
Number of subjects: 0
Study 7790793 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐dose, motorized, continuous traction
Number of subjects: 0
Study 7790793 — intervention group
Group type: COMPARATOR
Intervention: Sham or low‐dose traction
Number of subjects: 0
Study 2370347 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 T MRI
Number of subjects: 28
Study 2370347 — intervention group
Group type: COMPARATOR
Intervention: 0.5 T MRI
Number of subjects: 28
Study 348308 — intervention group
Group type: EXPERIMENTAL
Intervention: Cis-dichlorodiammineplatinum(II) single dose of 100 mg/m2 iv every 3-4 weeks
Number of subjects: 26
Study 348308 — intervention group
Group type: EXPERIMENTAL
Intervention: Cis-dichlorodiammineplatinum(II) continuous 5-day infusion of 20 mg/m2/day at 4-week intervals
Number of subjects: 26
Study 348308 — intervention group
Group type: COMPARATOR
Intervention: Cis-dichlorodiammineplatinum(II) (both schedules)
Number of subjects: 26
Study 30057231 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior CABG surgery (n=201)
Number of subjects: 591
Study 30057231 — intervention group
Group type: COMPARATOR
Intervention: No prior CABG surgery (n=390)
Number of subjects: 591
Study 30057231 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 591
Study 27839599 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic IOL with optic-haptic junction inferotemporally
Number of subjects: 305
Study 27839599 — intervention group
Group type: COMPARATOR
Intervention: Acrylic IOL with optic-haptic junction vertically
Number of subjects: 305
Study 27839599 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone IOL implanted inferotemporally
Number of subjects: 305
Study 25107947 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation with defibrillation (DF) testing
Number of subjects: 1077
Study 25107947 — intervention group
Group type: COMPARATOR
Intervention: ICD implantation without defibrillation (DF) testing
Number of subjects: 1077
Study 23973639 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 120 mg/day (Group A)
Number of subjects: 19
Study 23973639 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg/day (Group B)
Number of subjects: 19
Study 20558925 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture-guided triple therapy
Number of subjects: 701
Study 20558925 — intervention group
Group type: COMPARATOR
Intervention: Standard triple therapy
Number of subjects: 701
Study 18942246 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.125%) with epidural fentanyl (100 microg)
Number of subjects: 60
Study 18942246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.2%) with epidural fentanyl (100 microg)
Number of subjects: 60
Study 18942246 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine (0.125%) with epidural fentanyl (100 microg)
Number of subjects: 60
Study 15888211 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (0.04 mg/kg, I.V.)
Number of subjects: 14
Study 15888211 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 14
Study 12452221 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (9 microg/kg/h)
Number of subjects: 189
Study 12452221 — intervention group
Group type: COMPARATOR
Intervention: Morphine (0.045 mg/kg/h plus a bolus dose of 0.025 mg/kg)
Number of subjects: 189
Study 12452221 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.03 mg/kg/h)
Number of subjects: 189
Study 12452221 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 189
Study 9883223 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral alprostadil
Number of subjects: 249
Study 9883223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study 7611964 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction drain
Number of subjects: 0
Study 7611964 — intervention group
Group type: COMPARATOR
Intervention: No suction drain
Number of subjects: 0
Study 1971027 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin (2-40 mg, once daily)
Number of subjects: 0
Study 326493 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium meclofenamate (300 mg daily)
Number of subjects: 15
Study 326493 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg daily)
Number of subjects: 15
Study 326493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5-mg/saxagliptin 2.5-mg/metformin 1000-mg XR FCDP
Number of subjects: 84
Study 31266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10-mg/saxagliptin 5-mg/metformin 1000-mg XR FCDP
Number of subjects: 84
Study 31266654 — intervention group
Group type: COMPARATOR
Intervention: Food effect on both FCDPs
Number of subjects: 84
Study 31266654 — intervention group
Group type: COMPARATOR
Intervention: Female subjects
Number of subjects: 84
Study 31266654 — intervention group
Group type: COMPARATOR
Intervention: Safety profile of FCDPs
Number of subjects: 84
Study 28760287 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery-first approach
Number of subjects: 30
Study 28760287 — intervention group
Group type: COMPARATOR
Intervention: Conventional orthognathic surgery approach
Number of subjects: 30
Study 26328526 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned Caesarean Section (CS)
Number of subjects: 2570
Study 26328526 — intervention group
Group type: COMPARATOR
Intervention: Planned Vaginal Birth (VB)
Number of subjects: 2570
Study 24584741 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% intralipid infusion
Number of subjects: 25
Study 24584741 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 25
Study 24584741 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 25
Study 22962859 — intervention group
Group type: EXPERIMENTAL
Intervention: Casual outfit
Number of subjects: 179
Study 22962859 — intervention group
Group type: COMPARATOR
Intervention: Semiformal outfit
Number of subjects: 179
Study 22962859 — intervention group
Group type: COMPARATOR
Intervention: Formal outfit
Number of subjects: 179
Study 22962859 — intervention group
Group type: COMPARATOR
Intervention: Outfit (any type)
Number of subjects: 179
Study 19192468 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 198
Study 19192468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 17300592 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg daily
Number of subjects: 463
Study 17300592 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg daily
Number of subjects: 463
Study 17300592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study 15580175 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% CO2 challenge in Panic Disorder patients
Number of subjects: 43
Study 15580175 — intervention group
Group type: COMPARATOR
Intervention: 35% CO2 challenge in healthy volunteers
Number of subjects: 43
Study 15580175 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% CO2 challenge in male PD patients
Number of subjects: 43
Study 15580175 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% CO2 challenge
Number of subjects: 43
Study 11234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral arm swing
Number of subjects: 0
Study 11234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms reciprocally swinging
Number of subjects: 0
Study 11234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning-testing intervals of 400, 500, and 600 msec during ipsilateral backward arm swing
Number of subjects: 0
Study 11234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Onset of ipsilateral arm forward swing
Number of subjects: 0
Study 11234566 — intervention group
Group type: COMPARATOR
Intervention: Walking
Number of subjects: 0